PER 4.65% 9.0¢ percheron therapeutics limited

re: Ann: Change of Director's Interest No... "Absolutely, good...

  1. 35,749 Posts.
    lightbulb Created with Sketch. 554
    re: Ann: Change of Director's Interest No... "Absolutely, good to see. Why on earth this is at the SP it is now is beyuond me."

    There's a lot of jr. biotechs like that it's just how the sector values - while of course they all have the potential for large rewards majority of that is heavily back ended as can be seen when ever majors attribute milestone agreements with jr's. Value is rarely given in significant form until the point final approvals are granted and drugs enter the market when it comes fast.

    Another example -

    BIT slightly more cash than ANP - 3 x drugs in Phase II and only valued a couple of million higher.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢
Change
0.004(4.65%)
Mkt cap ! $81.13M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.